Compounds > beta-amyrin
Page last updated: 2024-08-25

beta-amyrin and Cardiometabolic Syndrome

beta-amyrin has been researched along with Cardiometabolic Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bishayee, A; Deshmukh, RR; Kumar, P; Kumar, S; Sharma, H1
Dinda, AK; Gupta, YK; Maulik, SK; Prabhakar, P; Reeta, KH1

Reviews

1 review(s) available for beta-amyrin and Cardiometabolic Syndrome

ArticleYear
Pentacyclic triterpenes: New tools to fight metabolic syndrome.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2018, Nov-15, Volume: 50

    Topics: Animals; Heart; Humans; Insulin Resistance; Liver; Metabolic Syndrome; Muscle, Skeletal; Oleanolic Acid; Oxidative Stress; Pentacyclic Triterpenes; Triterpenes; Ursolic Acid

2018

Other Studies

1 other study(ies) available for beta-amyrin and Cardiometabolic Syndrome

ArticleYear
α-Amyrin attenuates high fructose diet-induced metabolic syndrome in rats.
    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2017, Volume: 42, Issue:1

    Topics: Administration, Oral; Animals; Antihypertensive Agents; Antioxidants; Diet, Carbohydrate Loading; Dose-Response Relationship, Drug; Fructose; Gene Expression Regulation; Hyperglycemia; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Liver; Male; Metabolic Syndrome; Oleanolic Acid; Oxidative Stress; PPAR alpha; Random Allocation; Rats, Wistar

2017